Market entry planner

Everything downstream keys off a frozen formula. Stability data, the safety assessment, the ingredient list on the label: all of it describes one exact formulation, so a change after this point restarts the clock on whatever has already been done. Freeze the formula, including fragrance and colour variants, before commissioning any testing.

Confirm the ingredient suppliers, the manufacturer, and the primary packaging format. Stability and compatibility testing is run in the final packaging, so the pack decision belongs here, not after testing. Gather ingredient documentation (specifications, safety data sheets, allergen declarations) as you go: the safety assessment will need all of it, and incomplete documentation is the most common cause of delay later in the plan.

The backbone of the schedule. Real-time stability records pH, viscosity, density and organoleptic data over a 12-week protocol in line with Annex I section 5 and Commission Implementing Decision 2013/674/EU, with packaging compatibility assessed in parallel. A 4-week accelerated protocol with inferred shelf life exists and can shorten the path, but the 12-week protocol is more robust and is what we recommend budgeting for: an inferred shelf life is a model, and a surprise at month three of real time is far cheaper to find in testing than in the market.

The challenge test to ISO 11930 demonstrates that the preservative system controls microbial growth across the product’s life. The protocol spans 28 days of enumeration plus reporting, roughly six weeks end to end, and it runs comfortably inside the stability window, so started promptly it adds nothing to the overall timeline. Water-free and self-preserving formulations may justify a documented waiver instead, which the safety assessment records.

With test data and ingredient documentation in hand, the CPSR itself is the fast step: our standard turnaround is 48 hours, with a 24-hour Expedited service for urgent launches. The assessment is only as fast as its inputs, though, which is why step 2 tells you to gather the ingredient documentation early. And note what the assessment produces besides the safety conclusion: the confirmed INCI nomenclature, the mandatory warnings, and any restriction-driven conditions of use. The next step depends on those outputs.

The label carries the Article 19 particulars: Responsible Person name and address, nominal content, durability or period-after-opening, precautions, batch code, function, and the ingredient list in INCI nomenclature. Artwork design, the layout, brand and structure, can begin during the stability window, but the ingredient list, warnings and any restriction-driven conditions of use are confirmed by the safety assessment, not by the formula sheet. Finalising a label before the CPSR is signed is the most common and most expensive mistake we see: hundreds of clients have printed packaging with incorrect INCI names, or without realising a restriction applied to their formulation.

If the print schedule demands a head start, ask us for a pre-assessment, a label review, or our CPNP report, each of which confirms the ingredient position ahead of the full CPSR; otherwise, design early and finalise only against the signed assessment.

Printed packaging lead times vary widely by supplier and territory, commonly six to twelve weeks for printed components from overseas suppliers, and the order is placed only once the artwork is finalised against the signed assessment. This is why the CPSR sits on the critical path even at a 48-hour turnaround: it gates the print order, and the print lead time then runs in full. The false economy of ordering early to save weeks has paid for a great many reprints.

With the CPSR signed and the label settled, notification is quick: the Cosmetic Products Notification Portal for the EU and the Submit Cosmetic Product Notification portal for Great Britain, each gated on a Responsible Person established in that market. The two filings are independent, and a product sold in both markets makes both. Notification must be complete before the product is placed on the market, not after.

With the PIF compiled, notifications made and compliant stock in hand, the commercial launch is yours to time. Claims made in marketing are regulated as strictly as claims on the pack, so the same substantiation discipline applies to the website and advertising as to the label.